NUS1 Protein - Nogo-B Receptor

NUS1 Protein (NgBR)

Overview

Nus1 Protein Nogo B Receptor plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

NUS1 (Nogo-B Receptor, also known as NgBR) is an essential protein encoded by the [NUS1 gene](genes/NUS1) on chromosome 6p22.1. It functions as a receptor for Nogo-B (RTN4B), a member of the reticulon family, and plays critical roles in dolichol biosynthesis, protein N-glycosylation, and mitochondrial function. NUS1 has emerged as a significant player in neurodegenerative diseases, particularly [Parkinson's disease](/diseases/parkinsons-disease), where mutations have been linked to autosomal dominant PD. Additionally, NUS1 mutations cause a rare congenital disorder of glycosylation (NUS1-CDG). [@nus2019]

NUS1 Protein (NgBR)

Overview

Nus1 Protein Nogo B Receptor plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

NUS1 (Nogo-B Receptor, also known as NgBR) is an essential protein encoded by the [NUS1 gene](genes/NUS1) on chromosome 6p22.1. It functions as a receptor for Nogo-B (RTN4B), a member of the reticulon family, and plays critical roles in dolichol biosynthesis, protein N-glycosylation, and mitochondrial function. NUS1 has emerged as a significant player in neurodegenerative diseases, particularly [Parkinson's disease](/diseases/parkinsons-disease), where mutations have been linked to autosomal dominant PD. Additionally, NUS1 mutations cause a rare congenital disorder of glycosylation (NUS1-CDG). [@nus2019]

<div class="infobox infobox-protein"> [@nuscdg2020]
<table> [@nogob2018]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Nogo-B Receptor</th></tr> [@mevalonate2021]
<tr><td><strong>Protein Name</strong></td><td>Nogo-B receptor (NgBR)</td></tr> [@protein2017]
<tr><td><strong>Gene</strong></td><td>[NUS1](/genes/NUS1)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9BZE1](https://www.uniprot.org/uniprot/Q9BZE1)</td></tr>
<tr><td><strong>PDB IDs</td><td>5SV0, 5SV1, 6RQG</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>35 kDa (283 amino acids)</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Endoplasmic reticulum, cytoplasm, cell membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>NUS1 family</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Structure

NUS1/NgBR has a relatively simple architecture:

Domain Organization

| Domain | Position | Function |
|--------|----------|----------|
| Signal peptide | 1-20 | ER targeting |
| Extracellular domain | 21-160 | Nogo-B binding |
| Transmembrane helix | 161-183 | Membrane anchoring |
| Cytoplasmic domain | 184-283 | Signaling, enzyme interactions |

Key Structural Features

• Nogo-B binding — Specific interaction with Nogo-B (RTN4B)
• Prenyltransferase interaction — Forms complexes with DXR, DOXP synthase
• Dimerization — May function as homodimer
• Phosphorylation sites — Regulated by casein kinases

Normal Function

Dolichol Biosynthesis

NUS1 is essential for the final steps of dolichol synthesis:

Protein N-Glycosylation

The dolichol pathway produces the lipid carrier for N-glycosylation:

• Dolichol-P-P-GlcNAc2 — Initial glycan carrier
• Glycan transfer — OST complex transfers to nascent proteins
• Quality control — Proper glycosylation for protein folding

Mitochondrial Function

NUS1 maintains mitochondrial health:

• Morphology maintenance — Regulates mitochondrial dynamics
• Respiratory function — Supports OXPHOS
• [Apoptosis](/entities/apoptosis) regulation — Modulates intrinsic pathway

Neuronal Functions

In [neurons](/entities/neurons) specifically:

• Synaptic protein glycosylation — Essential for receptor function
• Dendritic morphology — Affects neuronal branching
• Axonal guidance — Nogo-B signaling in development

Role in Neurodegenerative Diseases

Parkinson's Disease

NUS1 is strongly implicated in PD:

Genetic findings:

• Q188H variant — Linked to autosomal dominant PD
• R239X variant — Associated with early-onset PD
• Genome-wide association — NUS1 locus increases PD risk

Therapeutic implications:

• Mevalonate pathway modulation
• Glycosylation-enhancing compounds
• Mitochondrial protectants

Congenital Disorder of Glycosylation (NUS1-CDG)

Recessive mutations cause severe developmental disorder:

• Developmental delay — Intellectual disability
• Seizures — Epileptic encephalopathy
• Dysmorphic features — Distinctive facial features
• Coagulopathy — Bleeding diathesis

Alzheimer's Disease

• APP glycosylation — Altered processing of [amyloid precursor protein](/entities/app-protein)
• [Tau](/proteins/tau) pathology — Glycosylation affects tau function
• Neuroinflammation — ER stress responses

Amyotrophic Lateral Sclerosis

• [TDP-43](/proteins/tdp-43) glycosylation — May affect aggregation
• Motor neuron vulnerability — Glycosylation defects

Therapeutic Approaches

Parkinson's Disease Strategies

| Approach | Target | Status |
|----------|--------|--------|
| Mevalonate pathway activators | Dolichol synthesis | Preclinical |
| Small molecule correctors | Protein folding | Research |
| Gene therapy | NUS1 expression | Future direction |
| Mitochondrial protectants | Mitochondrial function | In development |

NUS1-CDG Approaches

• Enzyme replacement — Not yet available
• Substrate supplementation — Mannose therapy trials
• Gene therapy — AAV-NUS1 in development

Clinical Assessment

Genetic Testing

• Sequencing — Identify pathogenic variants
• Carrier testing — For family members
• Prenatal diagnosis — For at-risk pregnancies

Biomarkers

| Marker | Significance |
|--------|--------------|
| Transferrin isoforms | Glycosylation status |
| Dolichol levels | Biosynthetic pathway activity |
| Mitochondrial markers | Complex activity |

Overview

Nus1 Protein Nogo B Receptor plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Nus1 Protein Nogo B Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

See Also

• NUS1 Gene
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• Congenital Disorders of Glycosylation
• Mevalonate Pathway
• Dolichol Synthesis
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)

References